Please select a service from below options
Choose Your Doctor
pick a specific Doctor to perform your service
Select Date and Time
Select date to see a timeline of available slots
User Detail Information
Please provide you contact details
Confirm your booking
About the COVID-19 Disease
CanWinn Foundation’s response to the COVID-19 Disease exemplifies its commitment to public health and community well-being. Through testing, treatment, vaccination campaigns, education, and research, the hospital has played a crucial role in mitigating the impact of the virus. As the global community continues to navigate the challenges posed by COVID-19, institutions like CanWinn Foundation serve as beacons of hope and resilience in the pursuit of a healthier and safer future.
The COVID-19 Disease , caused by the novel coronavirus SARS-CoV-2, has significantly impacted global health and wellbeing. In the face of this unprecedented crisis, organizations like CanWinn Foundation have emerged as key players in the fight against the virus. This article provides an overview of CanWinn Foundation’s dedicated efforts in response to the COVID-19 pandemic.
CanWinn Foundation is a renowned healthcare institution committed to promoting health, preventing diseases, and providing compassionate care to individuals in need. In the wake of the COVID-19 outbreak, CanWinn Foundation swiftly adapted its services and resources to address the challenges posed by the pandemic.
A word from our leaders
Dr. Sanjeev Choudhary
Marengo Asia Gurugram
CanWinn Foundation has taken a very unique step for the society.
Fortis Hospital Gurugram
Exceptional and in-depth service to common people by CanWinn
Dr. Arun Saroha
Max Hospital Gurugram
A Very dedicated team for the welfare of society.
Our Approach to COVID 19 Disease Treatment
The COVID-19 Disease has significantly impacted global health, leading to an urgent need for effective treatment strategies. As researchers and healthcare professionals work tirelessly to combat the virus, several approaches have emerged in the quest for successful COVID-19 disease treatment.
- Antiviral Medications: One key avenue in the treatment of COVID-19 involves antiviral medications designed to inhibit the replication of the SARS-CoV-2 virus. Remdesivir, initially developed for Ebola, has shown promise in reducing the recovery time for hospitalized patients. Other antivirals, such as favipiravir and molnupiravir, are also under investigation for their potential efficacy in treating COVID-19 Disease.
- Monoclonal Antibodies: Monoclonal antibodies are laboratory-produced molecules that mimic the immune system’s ability to fight off harmful pathogens. Several monoclonal antibody therapies, including casirivimab/imdevimab and sotrovimab, have received Emergency Use Authorization (EUA) for the treatment of mild to moderate COVID-19 cases, particularly in high-risk individuals.
- Corticosteroids: For severe cases of COVID-19 Disease characterized by cytokine storms and inflammatory responses, corticosteroids like dexamethasone have proven beneficial. These drugs help to suppress the immune system’s overactive response, reducing inflammation and preventing further damage to organs.
- Immunomodulators: Immunomodulatory drugs, such as tocilizumab and baricitinib, are being investigated for their potential to modulate the immune system’s response to the virus. These drugs target specific pathways involved in the inflammatory cascade, offering a therapeutic option for severe cases.
- Convalescent Plasma: Convalescent plasma therapy involves using blood plasma from individuals who have recovered from COVID-19 Disease. Rich in antibodies, this plasma is administered to patients to boost their immune response. While research on its efficacy is ongoing, convalescent plasma has been used as a treatment option, especially in the early stages of the pandemic.
- Oxygen Therapy and Ventilatory Support: In cases where COVID-19 leads to respiratory distress, oxygen therapy and ventilatory support become critical. High-flow nasal cannula (HFNC), non-invasive ventilation, and mechanical ventilation are employed to ensure adequate oxygen levels and support patients in respiratory distress.
Common COVID 19 Disease Symptoms
- Fever: One of the most common symptoms of COVID-19 is an elevated body temperature. A fever is generally considered to be 100.4°F (38°C) or higher.
- Cough: A persistent cough, often dry and irritating, is another prevalent symptom. It may start mild but can progress over time.
- Shortness of Breath: Difficulty breathing or shortness of breath is a serious symptom that may require immediate medical attention. It can range from mild to severe.
- Fatigue: Many individuals with COVID-19 experience fatigue or extreme tiredness, which may persist even after other symptoms improve.
- Muscle or Body Aches: Body aches and muscle pain are common symptoms and can be similar to those experienced with the flu.
- Loss of Taste or Smell: Some people infected with the virus may experience a sudden loss of taste or smell, known as anosmia. This symptom is distinctive to COVID-19.
COVID-19 Disease Less Common Symptoms:
- Sore Throat: While not as common as other symptoms, a sore throat can be a sign of COVID-19.
- Headache: Persistent headaches or migraines have been reported in some COVID-19 cases.
- Chills: Shivering or feeling unusually cold, accompanied by chills, can be an indication of infection.
- Nausea or Vomiting: Gastrointestinal symptoms like nausea or vomiting may occur, although they are less common.
- Congestion or Runny Nose: Some individuals with COVID-19 may experience nasal congestion or a runny nose, similar to a common cold.
- Diarrhea: Digestive issues, including diarrhea, have been observed in a subset of COVID-19 cases.